Cleerly (Series C extension)
Funding Details
Awarder
Inbox
Date Award
December 4, 2024
Vertical
Biotech and Health
Funding Amount
$106,000,000
Company Info
Founding Year
2017
Traction
Cleerly has achieved over 100% compounded annual growth over the last four years and has had its software commercially available for that duration.
Founders
James Min
Market
Cardiovascular Health
Location
United States
Coinvestors
Battery Ventures
Company Description

Cleerly is a cardiovascular imaging startup that analyzes CT scans of the heart using AI software to identify early-stage coronary artery disease, aiming to improve early detection of heart conditions.

Links